TickerFactsScreenerDevelopers

CRESCENT BIOPHARMA, INC. (CBIO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $316.2K2013: $82.1K2014: $212.6K2015: $268.6K2016: $704.2K2017: $294.1K2018: $125.6K2019: $144.9K2020: $68.5K2021: $14.9K2022: $84.2K2023: $21.4K2024: $10.0K2025: $919.0K$919.0K
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$919.0K+9115.8%
2024$10.0K-53.4%
2023$21.4K-74.6%
2022$84.2K+463.4%
2021$14.9K-78.2%
2020$68.5K-52.7%
2019$144.9K+15.4%
2018$125.6K-57.3%
2017$294.1K-58.2%
2016$704.2K+162.2%
2015$268.6K+26.3%
2014$212.6K+159.0%
2013$82.1K-74.0%
2012$316.2K—